US biotech firm Novavax said Thursday its two-shot Covid-19 vaccine showed an overall efficacy of 89.3 percent in a major Phase 3 clinical trial in Britain, and remained highly effective against a...
from NDTV News - Topstories https://ift.tt/36lyTbO
No comments:
Post a Comment